874 related articles for article (PubMed ID: 25499199)
21. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
23. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.
Huang DT; Angus DC; Kellum JA; Pugh NA; Weissfeld LA; Struck J; Delude RL; Rosengart MR; Yealy DM
Chest; 2009 Sep; 136(3):823-831. PubMed ID: 19363212
[TBL] [Abstract][Full Text] [Related]
24. [The value of pro-adrenomedullin in early diagnosis of sepsis].
Yan L; Cailan L; Hong L; Zheng L; Wei D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):739-42. PubMed ID: 26955700
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
26. Multidimensional Prognostic Index and pro-adrenomedullin plasma levels as mortality risk predictors in older patients hospitalized with community-acquired pneumonia: a prospective study.
Pilotto A; Dini S; Veronese N; Daragjati J; Miolo M; Mion MM; Fontana A; Lo Storto M; Zaninotto M; Bragato G; Cella A; Carraro P; Addante F; Copetti M; Plebani M
Panminerva Med; 2018 Sep; 60(3):80-85. PubMed ID: 29546738
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
[TBL] [Abstract][Full Text] [Related]
32. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
Lindstrom ST; Wong EK
Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
[TBL] [Abstract][Full Text] [Related]
33. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].
Kang FX; Wang RL; Yu KL; Wei Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):452-5. PubMed ID: 18687169
[TBL] [Abstract][Full Text] [Related]
34. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia.
Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T
Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948
[TBL] [Abstract][Full Text] [Related]
35. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.
Schuetz P; Litke A; Albrich WC; Mueller B
Curr Opin Infect Dis; 2013 Apr; 26(2):159-67. PubMed ID: 23434895
[TBL] [Abstract][Full Text] [Related]
36. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
[TBL] [Abstract][Full Text] [Related]
37. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
39. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
